Showing results (1-10 of 456) with videos related to

Sort By:
Pageof 46
Revue Neurologique|August 1, 2000
[Role of dopaminergic agonists]O Rascol, J L Montastruc
La Revue Du Praticien|February 1, 1994
[Drug therapy of vertigo]O Rascol, J L Montastruc
Clinical Neuropharmacology|October 1, 1992
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depressionJ L Montastruc, O Rascol, P Montastruc
Fundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L Montastruc
Revue Neurologique|January 1, 1990
[Neuroleptic malignant-like syndrome following levodopa withdrawal]O Rascol, F Salachas, J L Montastruc
La Revue Du Praticien|March 9, 1989
[Antiparkinsonian drugs]A Rascol, J L Montastruc, O Rascol
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?A Rascol, J L Montastruc, O Rascol
Clinical Neuropharmacology|June 1, 1993
Alopecia: an adverse effect of bromocriptineN Fabre, J L Montastruc, O Rascol
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-upJ L Montastruc, O Rascol, A Rascol
Pageof 46